nitroaspirin has been researched along with dinoprostone in 10 studies
| Studies (nitroaspirin) | Trials (nitroaspirin) | Recent Studies (post-2010) (nitroaspirin) | Studies (dinoprostone) | Trials (dinoprostone) | Recent Studies (post-2010) (dinoprostone) |
|---|---|---|---|---|---|
| 127 | 9 | 8 | 29,105 | 1,346 | 6,357 |
| Protein | Taxonomy | nitroaspirin (IC50) | dinoprostone (IC50) |
|---|---|---|---|
| Prostaglandin E2 receptor EP1 subtype | Homo sapiens (human) | 0.0155 | |
| Prostaglandin E2 receptor EP4 subtype | Homo sapiens (human) | 0.0031 | |
| Prostaglandin E2 receptor EP4 subtype | Rattus norvegicus (Norway rat) | 0.0021 | |
| Prostaglandin E2 receptor EP3 subtype | Homo sapiens (human) | 0.002 | |
| Prostaglandin E2 receptor EP2 subtype | Homo sapiens (human) | 0.0087 | |
| Prostacyclin receptor | Homo sapiens (human) | 0.26 | |
| Prostaglandin E2 receptor EP2 subtype | Rattus norvegicus (Norway rat) | 0.0052 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (30.00) | 18.2507 |
| 2000's | 5 (50.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bak, AW; Calignano, A; Cirino, G; Del Soldato, P; Li, P; McKnight, W; Wallace, JL | 1 |
| Kitamura, M; Konaka, A; Sugawa, Y; Takeuchi, K; Ukawa, H | 1 |
| Araki, H; Mizoguchi, H; Suzuki, K; Takeuchi, K; Ukawa, H; Yamamoto, H | 1 |
| del Soldato, P; Dicay, M; Fiorucci, S; McKnight, W; Mencarelli, A; Wallace, JL; Zamuner, SR | 1 |
| Breese, E; Del Soldato, P; Mitchell, J; Warner, T; Wood, E; Zacharowski, P | 1 |
| Corazzi, L; Corazzi, T; Gresele, P; Leone, M; Maucci, R | 1 |
| Kopelovich, L; Liu, X; Ouyang, N; Patlolla, JM; Rao, CV; Reddy, BS; Rigas, B; Simi, B; Steele, VE; Wang, CX | 1 |
| Mamuk, S; Melli, M | 1 |
| Abdellatif, KR; Chattopadhyay, M; Kashfi, K; Keefer, LK; Nia, KV; Pruski, A; Velazquez, CA | 1 |
| Delgadillo, D; Duarte, LF; Fernández-Ramires, R; Fernández-Soto, R; Jara, JA; Madariaga-Venegas, F; Molina-Berríos, A; Suarez, N; Urzúa, B | 1 |
10 other study(ies) available for nitroaspirin and dinoprostone
| Article | Year |
|---|---|
Cyclooxygenase-independent chemoprevention with an aspirin derivative in a rat model of colonic adenocarcinoma.
Topics: Adenocarcinoma; Animals; Aspirin; Azoxymethane; Colonic Neoplasms; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Disease Models, Animal; Isoenzymes; Male; Membrane Proteins; Mice; Pain Measurement; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Trinitrobenzenesulfonic Acid | 1998 |
Effect of nitric oxide-releasing aspirin derivative on gastric functional and ulcerogenic responses in rats: comparison with plain aspirin.
Topics: Animals; Aspirin; Cyclooxygenase Inhibitors; Dinoprostone; Gastric Acid; Gastric Acidity Determination; Male; Nitric Oxide; Rats; Rats, Sprague-Dawley; Regional Blood Flow; Stomach Ulcer | 1998 |
Cyclooxygenase-2 selective and nitric oxide-releasing nonsteroidal anti-inflammatory drugs and gastric mucosal responses.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Carrageenan; Cyclooxygenase 2; Dinoprostone; Edema; Ethanol; Gastric Mucosa; Gastrointestinal Contents; Hindlimb; Isoenzymes; Male; Nitrates; Nitric Oxide; Nitrites; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Sprague-Dawley; Stomach Diseases; Stomach Ulcer; Stress, Physiological; Wound Healing | 1998 |
Aspirin, but not NO-releasing aspirin (NCX-4016), interacts with selective COX-2 inhibitors to aggravate gastric damage and inflammation.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Drug Interactions; Gastric Mucosa; Gastritis; Isoenzymes; Lipoxins; Male; Neutropenia; Neutrophil Infiltration; Nitric Oxide; Peroxidase; Prostaglandin-Endoperoxide Synthases; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction | 2004 |
NSAIDs increase GM-CSF release by human synoviocytes: comparison with nitric oxide-donating derivatives.
Topics: 1-Methyl-3-isobutylxanthine; 4-(3-Butoxy-4-methoxybenzyl)-2-imidazolidinone; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Blotting, Western; Cells, Cultured; Cyclic AMP; Cyclic GMP; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Dinoprostone; Dose-Response Relationship, Drug; Flurbiprofen; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Indomethacin; Membrane Proteins; Naproxen; Nitric Oxide Donors; Nitroprusside; Phosphodiesterase Inhibitors; Prostaglandin-Endoperoxide Synthases; Purinones; Synovial Membrane; Time Factors | 2005 |
Direct and irreversible inhibition of cyclooxygenase-1 by nitroaspirin (NCX 4016).
Topics: Animals; Aspirin; Blood Platelets; Cyclooxygenase 1; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dialysis; Dinoprostone; Dose-Response Relationship, Drug; Hemostatics; Humans; Kinetics; Molecular Structure; Monocytes; Platelet Aggregation Inhibitors; Sheep; Spectrophotometry; Thrombin; Thromboxane B2; Time Factors | 2005 |
Nitric oxide-releasing aspirin and indomethacin are potent inhibitors against colon cancer in azoxymethane-treated rats: effects on molecular targets.
Topics: Acetates; Animals; Antineoplastic Agents; Aspirin; Azoxymethane; beta Catenin; Carcinogens; Colonic Neoplasms; Cyclooxygenase 2; Diet; Dinoprostone; Humans; Indoles; Male; Nitric Oxide Synthase Type II; Rats; Rats, Inbred F344 | 2006 |
Effect of aspirin, paracetamol and their nitric oxide donating derivatives on exudate cytokine and PGE2 production in zymosan-induced air pouch inflammation in rats.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Anti-Inflammatory Agents, Non-Steroidal; Aspirin; Dinoprostone; Dose-Response Relationship, Drug; Female; Immunoenzyme Techniques; Inflammation; Interleukin-1beta; Neutrophils; Nitrates; Nitric Oxide Donors; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha; Zymosan | 2007 |
Comparison between 3-Nitrooxyphenyl acetylsalicylate (NO-ASA) and O2-(acetylsalicyloxymethyl)-1-(pyrrolidin-1-yl)diazen-1-ium-1,2-diolate (NONO-ASA) as safe anti-inflammatory, analgesic, antipyretic, antioxidant prodrugs.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Antioxidants; Antipyretics; Aspirin; Dinoprostone; Disease Models, Animal; Edema; Fever; Gastric Mucosa; Hydrazines; Hyperalgesia; Lipid Peroxidation; Male; Malondialdehyde; Molecular Structure; Prodrugs; Rats; Rats, Wistar; Stomach Ulcer; Superoxide Dismutase; Tumor Necrosis Factor-alpha | 2010 |
Characterization of a novel antibiofilm effect of nitric oxide-releasing aspirin (NCX-4040) on Candida albicans isolates from denture stomatitis patients.
Topics: Antifungal Agents; Aspirin; Bacterial Adhesion; Biofilms; Candida albicans; Dinoprostone; Drug Resistance, Fungal; Fluconazole; Free Radical Scavengers; Humans; Inhibitory Concentration 50; Microbial Viability; Nitro Compounds; Stomatitis, Denture | 2017 |